• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外埃博拉病毒复制动力学的定量分析。

Quantification of Ebola virus replication kinetics in vitro.

机构信息

Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA 87545.

Department of Applied Mathematics, School of Mathematics, University of Leeds, Leeds LS2 9JT, UK.

出版信息

PLoS Comput Biol. 2020 Nov 2;16(11):e1008375. doi: 10.1371/journal.pcbi.1008375. eCollection 2020 Nov.

DOI:10.1371/journal.pcbi.1008375
PMID:33137116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7660928/
Abstract

Mathematical modelling has successfully been used to provide quantitative descriptions of many viral infections, but for the Ebola virus, which requires biosafety level 4 facilities for experimentation, modelling can play a crucial role. Ebola virus modelling efforts have primarily focused on in vivo virus kinetics, e.g., in animal models, to aid the development of antivirals and vaccines. But, thus far, these studies have not yielded a detailed specification of the infection cycle, which could provide a foundational description of the virus kinetics and thus a deeper understanding of their clinical manifestation. Here, we obtain a diverse experimental data set of the Ebola virus infection in vitro, and then make use of Bayesian inference methods to fully identify parameters in a mathematical model of the infection. Our results provide insights into the distribution of time an infected cell spends in the eclipse phase (the period between infection and the start of virus production), as well as the rate at which infectious virions lose infectivity. We suggest how these results can be used in future models to describe co-infection with defective interfering particles, which are an emerging alternative therapeutic.

摘要

数学建模已成功用于对许多病毒感染进行定量描述,但对于需要进行生物安全 4 级实验的埃博拉病毒,建模可以发挥关键作用。埃博拉病毒建模工作主要集中在体内病毒动力学上,例如在动物模型中,以帮助开发抗病毒药物和疫苗。但是,到目前为止,这些研究尚未详细说明感染周期,而这可以提供对病毒动力学的基本描述,从而更深入地了解其临床表现。在这里,我们获得了埃博拉病毒体外感染的一组多样化的实验数据集,然后利用贝叶斯推断方法来完全确定感染模型中的参数。我们的研究结果提供了有关受感染细胞处于潜伏期(感染和开始产生病毒之间的时间段)的时间分布的见解,以及传染性病毒颗粒丧失感染力的速度。我们建议如何在未来的模型中使用这些结果来描述具有缺陷干扰颗粒的合并感染,这些颗粒是一种新兴的替代治疗方法。

相似文献

1
Quantification of Ebola virus replication kinetics in vitro.体外埃博拉病毒复制动力学的定量分析。
PLoS Comput Biol. 2020 Nov 2;16(11):e1008375. doi: 10.1371/journal.pcbi.1008375. eCollection 2020 Nov.
2
Modelling Ebola virus dynamics: Implications for therapy.埃博拉病毒动力学建模:对治疗的启示。
Antiviral Res. 2016 Nov;135:62-73. doi: 10.1016/j.antiviral.2016.10.004. Epub 2016 Oct 12.
3
Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription.丝氨酸-精氨酸蛋白激酶 1 调节埃博拉病毒转录。
mBio. 2020 Feb 25;11(1):e02565-19. doi: 10.1128/mBio.02565-19.
4
Recombinant Lloviu virus as a tool to study viral replication and host responses.重组 Lloviu 病毒作为研究病毒复制和宿主反应的工具。
PLoS Pathog. 2022 Feb 4;18(2):e1010268. doi: 10.1371/journal.ppat.1010268. eCollection 2022 Feb.
5
Entry of Ebola Virus is an Asynchronous Process.埃博拉病毒的进入是一个异步过程。
J Infect Dis. 2015 Oct 1;212 Suppl 2:S199-203. doi: 10.1093/infdis/jiv189. Epub 2015 May 3.
6
Ebola virus defective interfering particles and persistent infection.埃博拉病毒缺陷干扰颗粒与持续性感染
Virology. 1999 Sep 15;262(1):114-28. doi: 10.1006/viro.1999.9915.
7
Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study.I 型干扰素抑制的定量分析:以埃博拉病毒为例。
Viruses. 2021 Dec 4;13(12):2441. doi: 10.3390/v13122441.
8
Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.埃博拉病毒表面糖蛋白的脱落是细胞毒性自我调节的一种机制,并且对病毒感染性有直接影响。
J Infect Dis. 2015 Oct 1;212 Suppl 2:S322-8. doi: 10.1093/infdis/jiv268. Epub 2015 Jun 19.
9
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.反向遗传学表明,埃博拉病毒糖蛋白的蛋白水解加工对于在细胞培养中的复制并非必不可少。
J Virol. 2002 Jan;76(1):406-10. doi: 10.1128/jvi.76.1.406-410.2002.
10
Teicoplanin inhibits Ebola pseudovirus infection in cell culture.替考拉宁在细胞培养中抑制埃博拉假病毒感染。
Antiviral Res. 2016 Jan;125:1-7. doi: 10.1016/j.antiviral.2015.11.003. Epub 2015 Nov 14.

引用本文的文献

1
Intracellular and extracellular dynamics of herpes simplex virus 1 DNA and infectious particles in epithelial and neuronal cells.单纯疱疹病毒1型DNA及感染性颗粒在上皮细胞和神经元细胞中的细胞内和细胞外动态变化
bioRxiv. 2025 May 13:2025.05.13.653775. doi: 10.1101/2025.05.13.653775.
2
Practical parameter identifiability and handling of censored data with Bayesian inference in mathematical tumour models.在数学肿瘤模型中,通过贝叶斯推断进行实用参数可识别性和有界数据处理。
NPJ Syst Biol Appl. 2024 Aug 14;10(1):89. doi: 10.1038/s41540-024-00409-6.
3
Incorporating Intracellular Processes in Virus Dynamics Models.

本文引用的文献

1
Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment.埃博拉病毒感染与治疗过程中宿主动态的建模挑战。
Viruses. 2020 Jan 16;12(1):106. doi: 10.3390/v12010106.
2
Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.数学模型确定适应性免疫在控制棉鼠呼吸道合胞病毒中的关键作用。
J R Soc Interface. 2019 Nov 29;16(160):20190389. doi: 10.1098/rsif.2019.0389. Epub 2019 Nov 27.
3
'Make Ebola a thing of the past': first vaccine against deadly virus approved.
将细胞内过程纳入病毒动力学模型。
Microorganisms. 2024 Apr 30;12(5):900. doi: 10.3390/microorganisms12050900.
4
Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.靶向宿主O-连接聚糖生物合成会影响埃博拉病毒的复制效率,并揭示埃博拉病毒糖蛋白上不同的N-乙酰半乳糖胺基转移酶(GalNAc-T)受体位点偏好。
J Virol. 2024 Jun 13;98(6):e0052424. doi: 10.1128/jvi.00524-24. Epub 2024 May 17.
5
The reproduction number and its probability distribution for stochastic viral dynamics.随机病毒动力学的繁殖数及其概率分布。
J R Soc Interface. 2024 Jan;21(210):20230400. doi: 10.1098/rsif.2023.0400. Epub 2024 Jan 24.
6
The effect of random virus failure following cell entry on infection outcome and the success of antiviral therapy.随机病毒在进入细胞后发生故障对感染结果和抗病毒治疗的成功的影响。
Sci Rep. 2023 Oct 11;13(1):17243. doi: 10.1038/s41598-023-44180-w.
7
Inactivation of Ebola Virus and SARS-CoV-2 in Cell Culture Supernatants and Cell Pellets by Gamma Irradiation.γ 射线辐照对细胞培养上清液和细胞沉淀中埃博拉病毒和 SARS-CoV-2 的灭活作用。
Viruses. 2022 Dec 23;15(1):43. doi: 10.3390/v15010043.
8
Estimation of virus-mediated cell fusion rate of SARS-CoV-2.估算 SARS-CoV-2 介导的病毒细胞融合率。
Virology. 2022 Oct;575:91-100. doi: 10.1016/j.virol.2022.08.016. Epub 2022 Sep 7.
9
Inactivation Methods for Experimental Nipah Virus Infection.实验性尼帕病毒感染的灭活方法。
Viruses. 2022 May 15;14(5):1052. doi: 10.3390/v14051052.
“让埃博拉成为历史”:首款针对这种致命病毒的疫苗获批
Nature. 2019 Nov;575(7783):425-426. doi: 10.1038/d41586-019-03490-8.
4
Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses.通过结合体外检测和计算机分析揭示人类呼吸道合胞病毒的关键特性。
PLoS One. 2019 Apr 15;14(4):e0214708. doi: 10.1371/journal.pone.0214708. eCollection 2019.
5
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.埃博拉病毒在非人灵长类动物中的动态变化为研究病毒的免疫发病机制和抗病毒策略提供了线索。
Nat Commun. 2018 Oct 1;9(1):4013. doi: 10.1038/s41467-018-06215-z.
6
Experimental Ebola drugs face tough test in war zone.实验性埃博拉药物在战区面临严峻考验。
Nature. 2018 Sep;561(7721):14. doi: 10.1038/d41586-018-06132-7.
7
The defective component of viral populations.病毒群体中的缺陷成分。
Curr Opin Virol. 2018 Dec;33:74-80. doi: 10.1016/j.coviro.2018.07.014. Epub 2018 Aug 9.
8
Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling.病毒复制动力学与抗病毒治疗策略的数学分析:从基本模型到基于年龄的多尺度建模
Front Microbiol. 2018 Jul 11;9:1546. doi: 10.3389/fmicb.2018.01546. eCollection 2018.
9
A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents.一种新型的、具有年龄结构的丙型肝炎病毒生命周期多尺度模型,用于研究感染期间及直接作用抗病毒药物治疗过程。
Front Microbiol. 2018 Apr 4;9:601. doi: 10.3389/fmicb.2018.00601. eCollection 2018.
10
Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.法匹拉韦抗埃博拉病毒的疗效:食蟹猴中的转化研究。
PLoS Med. 2018 Mar 27;15(3):e1002535. doi: 10.1371/journal.pmed.1002535. eCollection 2018 Mar.